| The projected timeframe until cervical cancer elimination in Australia: a modelling study MT Hall, KT Simms, JB Lew, MA Smith, JML Brotherton, M Saville, ... The Lancet Public Health 4 (1), e19-e27, 2019 | 409 | 2019 |
| Bleeding and thrombotic complications in the use of extracorporeal membrane oxygenation J Thomas, V Kostousov, J Teruya Seminars in thrombosis and hemostasis 44 (01), 020-029, 2018 | 251 | 2018 |
| Primary HPV testing versus cytology-based cervical screening in women in Australia vaccinated for HPV and unvaccinated: effectiveness and economic assessment for the National … JB Lew, KT Simms, MA Smith, M Hall, YJ Kang, XM Xu, M Caruana, ... The Lancet Public Health 2 (2), e96-e107, 2017 | 178 | 2017 |
| Projected future impact of HPV vaccination and primary HPV screening on cervical cancer rates from 2017–2035: example from Australia MT Hall, KT Simms, JB Lew, MA Smith, M Saville, K Canfell PloS one 13 (2), e0185332, 2018 | 77 | 2018 |
| Transitioning from cytology-based screening to HPV-based screening at longer intervals: implications for resource use MA Smith, D Gertig, M Hall, K Simms, JB Lew, M Malloy, M Saville, ... BMC health services research 16, 1-14, 2016 | 41 | 2016 |
| Impact of disruptions and recovery for established cervical screening programs across a range of high-income country program designs, using COVID-19 as an example: A modelled … MA Smith, EA Burger, A Castanon, IMCM de Kok, SJB Hanley, M Rebolj, ... Preventive medicine 151, 106623, 2021 | 40 | 2021 |
| Optimal management strategies for primary HPV testing for cervical screening: cost-effectiveness evaluation for the National Cervical Screening Program in Australia KT Simms, M Hall, MA Smith, JB Lew, S Hughes, S Yuill, I Hammond, ... PLoS One 12 (1), e0163509, 2017 | 31 | 2017 |
| Could HPV testing on self-collected samples be routinely used in an organized cervical screening program? A modeled analysis MA Smith, MT Hall, M Saville, JML Brotherton, KT Simms, JB Lew, ... Cancer Epidemiology, Biomarkers & Prevention 30 (2), 268-277, 2021 | 30 | 2021 |
| High rates of cirrhosis and severe clinical events in patients with HBV/HDV co-infection: longitudinal analysis of a German cohort JH Bockmann, M Grube, V Hamed, J von Felden, J Landahl, M Wehmeyer, ... BMC gastroenterology 20, 1-6, 2020 | 30 | 2020 |
| The past, present and future impact of HIV prevention and control on HPV and cervical disease in Tanzania: a modelling study MT Hall, MA Smith, KT Simms, RV Barnabas, K Canfell, JM Murray PloS one 15 (5), e0231388, 2020 | 30 | 2020 |
| Pathways to a cancer-free future: a protocol for modelled evaluations to maximize the future impact of interventions on cervical cancer in Australia LS Velentzis, MA Smith, KT Simms, JB Lew, M Hall, S Hughes, S Yuill, ... Gynecologic Oncology 152 (3), 465-471, 2019 | 19 | 2019 |
| The combined impact of implementing HPV immunisation and primary HPV screening in New Zealand: Transitional and long-term benefits, costs and resource utilisation implications MT Hall, MA Smith, JB Lew, J O'Hallahan, G Fentiman, H Neal, M Sage, ... Gynecologic Oncology 152 (3), 472-479, 2019 | 14 | 2019 |
| The projected timeframe until cervical cancer elimination in Australia: a modelling study. Lancet Public Health. 4 (1): e19–e27 MT Hall, KT Simms, JB Lew, MA Smith, JM Brotherton, M Saville, ... | 14 | 2019 |
| Potential for HPV vaccination and primary HPV screening to reduce cervical cancer disparities: Example from New Zealand MA Smith, M Hall, JB Lew, K Canfell Vaccine 36 (42), 6314-6324, 2018 | 13 | 2018 |
| Elimination of cervical cancer in Tanzania: modelled analysis of elimination in the context of endemic HIV infection and active HIV control MT Hall, MA Smith, KT Simms, R Barnabas, JM Murray, K Canfell International journal of cancer 149 (2), 297-306, 2021 | 9 | 2021 |
| The projected timeframe until cervical cancer elimination in Australia: a modelling study. Lancet Public Health. 2019; 4 (1): e19–27 MT Hall, KT Simms, JB Lew, MA Smith, JML Brotherton, M Saville | 9 | |
| Australia on-track to be the first country to achieve cervical cancer elimination K Canfell, M Hall, K Simms, M Smith, M Saville Mortality 1, 80, 2018 | 6 | 2018 |
| A modelled evaluation of the impact of COVID-19 on breast, bowel, and cervical cancer screening programmes in Australia C Nickson, MA Smith, E Feletto, LS Velentzis, K Broun, S Deij, P Grogan, ... Elife 12, e82818, 2023 | 5 | 2023 |
| Benefits, harms and cost-effectiveness of cervical screening, triage and treatment strategies for women in the general population KT Simms, A Keane, DTN Nguyen, M Caruana, MT Hall, G Lui, ... Nature Medicine 29 (12), 3050-3058, 2023 | 2 | 2023 |
| Evaluation of the benefits and harms of alternative strategies for cervical screening and treatment in women living with HIV: modelling to support WHO 2021 cervical screening … M Hall, K Simms, J Murray, A Keane, TND Nguyen, M Caruana, G Liu, ... | 1 | 2022 |
